American Association for Cancer Research
Browse

Supplementary Table 2 from History of Diabetes and Risk of Head and Neck Cancer: A Pooled Analysis from the International Head and Neck Cancer Epidemiology Consortium

Download (49.71 kB)
journal contribution
posted on 2023-03-31, 13:49 authored by Marni Stott-Miller, Chu Chen, Shu-Chun Chuang, Yuan-Chin Amy Lee, Stefania Boccia, Hermann Brenner, Gabriela Cadoni, Luigino Dal Maso, Carlo La Vecchia, Philip Lazarus, Fabio Levi, Keitaro Matsuo, Hal Morgenstern, Heiko Müller, Joshua Muscat, Andrew F. Olshan, Mark P. Purdue, Diego Serraino, Thomas L. Vaughan, Zuo-Feng Zhang, Paolo Boffetta, Mia Hashibe, Stephen M. Schwartz

PDF file - 49K

History

ARTICLE ABSTRACT

Background: A history of diabetes is associated with an increased risk of several types of cancers. Whether diabetes is a risk factor for head and neck cancer (HNC) has received little attention.Methods: We pooled data from 12 case–control studies including 6,448 cases and 13,747 controls, and estimated OR and 95% CI for the associations between diabetes and HNC, adjusted for age, education level, sex, race/ethnicity, study center, cigarette smoking, alcohol use, and body mass index.Results: We observed a weak association between diabetes and the incidence of HNC overall (OR, 1.09; 95% CI: 0.95–1.24). However, we observed a modest association among never smokers (OR, 1.59; 95% CI: 1.22–2.07), and no association among ever smokers (OR, 0.96; 95% CI: 0.83–1.11); likelihood ratio test for interaction P = 0.001.Conclusion: A history of diabetes was weakly associated with HNC overall, but we observed evidence of effect modification by smoking status, with a positive association among those who never smoked cigarettes.Impact: This study suggests that glucose metabolism abnormalities may be a HNC risk factor in subgroups of the population. Prospective studies incorporating biomarkers are needed to improve our understanding of the relationship between diabetes and HNC risk, possibly providing new strategies in the prevention of HNC. Cancer Epidemiol Biomarkers Prev; 21(2); 294–304. ©2011 AACR.

Usage metrics

    Cancer Epidemiology, Biomarkers & Prevention

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC